GSK plc Profit Loss From Continuing Operations Attributable To Noncontrolling Interests
GSK plc (GLAXF) reported Profit Loss From Continuing Operations Attributable To Noncontrolling Interests of GBP 376.00 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-03.
Financial Statements › Notes
ifrs-full:ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests · last filed 2025-03-03
| Period end | Profit Loss From Continuing Operations Attributable To Noncontrolling Interests 12 month |
|---|---|
| 2024-12-31 | 376.00M GBP 20-F · filed 2025-03-03 |
| 2023-12-31 | 380.00M GBP 20-F · filed 2025-03-03 |
| 2022-12-31 | 460.00M GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | 200.00M GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | 230.00M GBP 20-F · filed 2023-03-10 |